Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”), a clinical-stage macrophage reprogramming immunotherapy company, today announced that it will present two poster abstracts at the ...

With a three-minute presentation on cancer research, Kirstin Rollins, a PhD student in the Department of Molecular, Cellular, ...

These same capabilities could also enable macrophage therapy for osteoarthritis, says Sowmya Viswanathan of the University Health Network in Toronto. A macrophage type called M2 produces cell ...

To grow, cancer tumors must hijack the immune system for their needs. One of the main tricks that most tumors use is to ...

Findings could open up new avenue for precision therapy for the most commonly diagnosed cancer among women that killed ...

These findings open new doors for macrophage-based therapies, which could enhance myocardial repair without relying on exogenous stem cell transplantation. Read the full story here . Heart_Disease ...

Study reveals how a new IgE antibody therapy reactivates immune cells, offering a promising approach to fighting ovarian ...

Researchers in South Korea have proposed a novel cancer immunotherapy approach that could complement existing CAR-T (Chimeric ...

Pheast Therapeutics has treated the first subject in a multi-centre Phase I trial for PHST001, aimed at treating advanced ...

The macrophages also showcased morphological changes. “Looking at the world of cancer immunology and cell therapy, it is largely driven by biology. However, in addition to the biology of the cell, it ...